Home » Stocks » OFIX

Orthofix Medical Inc. (OFIX)

Stock Price: $41.72 USD 1.32 (3.27%)
Updated May 13, 2021 4:00 PM EDT - Market closed
After-hours: $41.72 0.00 (-0.01%) May 13, 4:07 PM
Market Cap 817.56M
Revenue (ttm) 407.33M
Net Income (ttm) -28.96M
Shares Out 19.56M
EPS (ttm) -1.50
PE Ratio n/a
Forward PE 60.24
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $41.72
Previous Close $40.40
Change ($) 1.32
Change (%) 3.27%
Day's Open 40.85
Day's Range 40.77 - 42.15
Day's Volume 115,883
52-Week Range 28.03 - 48.50

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

LEWISVILLE, Texas--(BUSINESS WIRE)--The OrthoNext™ digital platform enables selection of device size and the optimal positioning for the patient's body prior to the surgical procedure.

3 days ago - Business Wire

Strong sales of Orthofix's (OFIX) M6-C artificial disc and FITBONE lengthening nail drive its Q1 top line.

1 week ago - Zacks Investment Research

Orthofix (OFIX) delivered earnings and revenue surprises of 142.86% and 10.68%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended March 31, 2021. Net sales were $105.6 million, earnings per share (“EPS...

1 week ago - Business Wire

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix announces exclusive U.S. license for IGEA's bone and joint stimulation devices to expand the Company's Bone Growth Therapy offerings.

2 weeks ago - Business Wire

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced that it plans to release financial results fo...

3 weeks ago - Business Wire

Here are five orthopedic device stocks, Integra (IART), Conformis (CFMS), SeaSpine (SPNE), Zimmer Biomet (ZBH), Orthofix (OFIX), which are expected to continue their run over the next few months.

Other stocks mentioned: CFMS, IART, NUVA, SPNE, ZBH
3 weeks ago - Zacks Investment Research

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix announces the FDA 510(k) clearance and first patient implant of the FORZA™ Ti TLIF Spacer System with Nanovate Technology.

3 weeks ago - Business Wire

These 3D stocks have proven to be instrumental in improving the quality of healthcare outcomes The post 3 3D Stocks That Can Advance the World of Healthcare appeared first on InvestorPlace. More From In...

Other stocks mentioned: MDT, SSYS
1 month ago - InvestorPlace

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Announces Board Chair Transition; Catherine Burzik nominated for election as the next Chair of the Company's Board of Directors.

1 month ago - Business Wire

Orthofix's (OFIX) CONSTRUX Mini Ti Spacer System, designed with nanoscale surface is the first 3D-printed titanium interbody, was launched to enhance ACDF procedures.

1 month ago - Zacks Investment Research

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix launches the Company's first 3D-printed titanium cervical interbody, the CONSTRUX™ Mini Ti Cervical Spacer System with Nanovate™ Technology.

1 month ago - Business Wire

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix launches recycling initiative for its bone growth therapy devices, becoming the first and only company in the U.S. to offer such a program.

2 months ago - Business Wire

Orthofix (OFIX) registers improvement in Global Spine segment's revenues during Q4 due to strength in its spinal implants portfolio.

2 months ago - Zacks Investment Research

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the fourth quarter and fiscal year ended December 31, 2020. Net sales for the fourth quar...

2 months ago - Business Wire

With FITBONE, Orthofix (OFIX) claims itself to be the only orthopedic company that offers a comprehensive portfolio of both internal and external fixation solutions for limb reconstruction.

3 months ago - Zacks Investment Research

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced that President and Chief Executive Officer Jo...

3 months ago - Business Wire

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced that it plans to release financial results fo...

3 months ago - Business Wire

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX) today announced preliminary unaudited fourth quarter 2020 net sales of approximately $118 million, a decrease of 3% on a reported ...

4 months ago - Business Wire

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX) today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will participate in...

4 months ago - Business Wire

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX) today announced that President and Chief Executive Officer Jon Serbousek will participate in a fireside chat during the Stifel 202...

6 months ago - Business Wire

Orthofix Medical Inc. (OFIX) CEO Jon Serbousek on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Orthofix (OFIX) delivered earnings and revenue surprises of 247.62% and 29.28%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the third quarter ended September 30, 2020. Net sales were $111.0 million, earnings per s...

6 months ago - Business Wire

Orthofix (OFIX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release finan...

6 months ago - Business Wire

Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal healing products, today announced support for the U.S.

8 months ago - Business Wire

Investors continue to hope for a generous fiscal package to tackle the pandemic, but remain cautious of the developments so far as the process has become highly politicized. Our deep learning algorithms...

Other stocks mentioned: CACI, PLUS, SYX, TGNA
9 months ago - Forbes

Orthofix Medical, Inc. (OFIX) CEO Jon Serbousek on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Orthofix (OFIX) delivered earnings and revenue surprises of 26.25% and 35.94%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the second quarter ended June 30, 2020.

9 months ago - Business Wire

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX) today announced that President and Chief Executive Officer Jon Serbousek will present at the Canaccord Genuity 40th Annual Growth ...

9 months ago - Business Wire

Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release finan...

9 months ago - Business Wire

Orthofix (OFIX) rides high on dual regulatory clearances for its deformity correction system, thus solidifying its pediatric orthopedics portfolio.

9 months ago - Zacks Investment Research

Orthofix Medical, Inc. (OFIX) CEO Jon Serbousek on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Orthofix (OFIX) delivered earnings and revenue surprises of -18.18% and 0.31%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Amid the pandemonium on the account of coronavirus, we look into three stocks that have been struggling to cope with the scenario.

Other stocks mentioned: ABMD, BDX
1 year ago - Zacks Investment Research

Orthofix (OFIX) pledges support for the continuation of the FDA's Class III status of BGS devices.

1 year ago - Zacks Investment Research

We are upbeat about the year-over-year revenue growth recorded by majority of Orthofix's (OFIX) key operating segments in Q4.

1 year ago - Zacks Investment Research

Orthofix Medical, Inc. (OFIX) CEO Jon Serbousek on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Orthofix (OFIX) delivered earnings and revenue surprises of 0.00% and -1.14%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Orthofix Medical, Inc. (OFIX) CEO Bradley Mason on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Orthofix (OFIX) delivered earnings and revenue surprises of -21.15% and -4.46%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

In the near future, there is a probability of 3D-printed implantable organs becoming a reality, thereby increasing the number of lives saved.

Other stocks mentioned: MDT, SYK
1 year ago - Zacks Investment Research

Orthofix Medical's (OFIX) Q2 performance across all business segments has been commendable, except for spinal implants.

1 year ago - Zacks Investment Research

Orthofix Medical, Inc. (OFIX) CEO Bradley Mason on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Orthofix (OFIX) delivered earnings and revenue surprises of -30.00% and 0.13%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Lower investment in MedTech might prove to be a concern, more so as gains within this space are staggering.

Other stocks mentioned: BIOL, DXCM, HAE
1 year ago - Zacks Investment Research

About OFIX

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fi... [Read more...]

Industry
Medical Devices
Founded
1987
Stock Exchange
NASDAQ
Ticker Symbol
OFIX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for OFIX stock is "Buy." The 12-month stock price forecast is 54.00, which is an increase of 29.43% from the latest price.

Price Target
$54.00
(29.43% upside)
Analyst Consensus: Buy